Neuroimaging Biomarker

Alzheimer's sickness Biomarkers, with emphasis on cerebrospinal fluid biomarkers and neuroimaging. Mild Cognitive Impairment (MCI) of Neuroimaging-biomarkers permit an early diagnosis in preclinical levels of Alzheimer’s ailment. Biomarker changes in patients with late-onset AD, inclusive of findings from research using structural and practical magnetic resonance imaging (MRI), advanced MRI strategies (diffusion tensor imaging, magnetic resonance spectroscopy, perfusion), positron emission tomography with fluorodeoxyglucose, amyloid tracers, and different neurochemical tracers, and CSF protein levels. The dynamic measures of these imaging biomarkers are used to predict the sickness progression inside the early levels and improve the evaluation of healing efficacy in these diseases in destiny clinical trials.

•              Neuroimaging Biomarkers in Personalized Medicine

•              Neuroimaging Genetics

    Related Conference of Neuroimaging Biomarker

    December 15-16, 2025

    20th Annual Congress on Neuroscience

    Paris, France
    January 29-30, 2026

    29th International Conference on Viral Infections & Virology

    Aix-en-Provence, France
    February 02-03, 2026

    7th Global Summit on Brain Disorders and Therapeutics

    Paris, France
    February 12-13, 2026

    8th World Conference on Neuroscience

    Singapore City, Singapore
    March 09-10, 2026

    7th International Conference on Neurologists

    Singapore City, Singapore
    April 23-24, 2026

    8th World Depression Congress

    Paris, France
    May 14-15, 2026

    9th World Conference on Neuroscience

    Rome, Italy
    May 18-19, 2026

    38th International conference on Mental Health and Psychiatry

    Aix-en-Provence, France
    June 22-23, 2026

    7th World Congress on Sleep Disorders and Therapeutics

    Amsterdam, Netherlands
    June 22-23, 2026

    38th World Conference on Neurology

    Barcelona, Spain
    June 29-30, 2026

    37th Conference on Clinical Neuroscience and Neurogenetics

    Aix-en-Provence, France
    June 29-30, 2026

    39th European Neurology Congress

    London, UK
    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands

    Neuroimaging Biomarker Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in